MediWound’s US launch of its topical gel for burns delayed to Q1 due to manufacturing ‘deviation’

Anna Brown

News Reporter

MediWound has delayed the US launch of its topical gel for burns to early next year due to a manufacturing “deviation.” The company initially planned …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

MediWound’s US launch of its topical gel for burns delayed to Q1 due to manufacturing ‘deviation’

Anna Brown

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Stem cell startup spun out of George Church’s lab raises $75M

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

Here's what today's Fed rate cut means for biotech, pharma and venture capital

Upstream Bio files for IPO in sign of life for biotech public offerings

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

Breaking down silos with a new quantitative approach to drug development

Medi­Wound’s US launch of its top­i­cal gel for burns de­layed to Q1 due to man­u­fac­tur­ing ‘de­vi­a­tion’

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

MediWound’s US launch of its topical gel for burns delayed to Q1 due to manufacturing ‘deviation’